Prepare for your visit

Melissa Layne Broaddus

Optometrist · Memphis, TN · NPI 1376977439

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$1,691.95

in general payments reported to CMS, 2019-2025 · $532 in 2025

The $532 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).

Who reported paying

General payments only, top 6 by amount.

Coopervision INC. $644.56
Bausch & Lomb Americas INC. $418.65
Sight Sciences, INC. $202.68
Tarsus Pharmaceuticals, INC. $121.70
Sun Pharmaceutical Industries INC. $96.14
Abbvie INC. $92.16

Drugs and devices associated with these payments

Myday Contact Lens Infuse Tearcare System Xdemvy Misight Contact Lens Cequa Durysta Clariti Contact Lens Miebo Biofinity Contact Lens

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Melissa Broaddus listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/17439/melissa-layne-broaddus